Literature DB >> 28381199

2014 Chinese guidelines for secondary prevention of ischemic stroke and transient ischemic attack.

Yongjun Wang1, Ming Liu2, Chuanqiang Pu3.   

Abstract

Ischemic stroke and transient ischemic attack (TIA) are the most common cerebrovascular disorder and leading cause of death in China. The Effective secondary prevention is the vital strategy for reducing stroke recurrence. The aim of this guideline is to provide the most updated evidence-based recommendation to clinical physicians from the prior version. Control of risk factors, intervention for vascular stenosis/occlusion, antithrombotic therapy for cardioembolism, and antiplatelet therapy for noncardioembolic stroke are all recommended, and the prevention of recurrent stroke in a variety of uncommon causes and subtype provided as well. We modified the level of evidence and recommendation according to part of results from domestic RCT in order to facility the clinical practice.

Entities:  

Keywords:  Chinese; Stroke; neurology; recommendations; secondary prevention; transient ischemic attack

Mesh:

Year:  2017        PMID: 28381199     DOI: 10.1177/1747493017694391

Source DB:  PubMed          Journal:  Int J Stroke        ISSN: 1747-4930            Impact factor:   5.266


  35 in total

1.  Trends and Risk Factors Associated With Stroke Recurrence in China, 2007-2018.

Authors:  Jie Xu; Xing Zhang; Aoming Jin; Yuesong Pan; Zixiao Li; Xia Meng; Yongjun Wang
Journal:  JAMA Netw Open       Date:  2022-06-01

2.  Design of stroke imaging package study of intracranial atherosclerosis: a multicenter, prospective, cohort study.

Authors:  Qianqian Lin; Xiaoyun Liu; Beilei Chen; Daishi Tian; Changyun Liu; Ailian Du; Baoquan Lu; Guangzhi Liu; Bo Wu; Litao Li; Hui Liang; Shiwen Wu; Zhimin Shi; Tao Gong; Zhongrui Yan; Qinjian Sun; Le Fang; Lifang Zhang; Degang Sun; Mingli Li; Wei-Hai Xu
Journal:  Ann Transl Med       Date:  2020-01

3.  Clopidogrel increases risk of pneumonia compared with aspirin in acute ischemic minor stroke patients.

Authors:  Zhangfeng Yu; Hua Zhou; Baoshuai Shan; Jianzhong Fu; Hao Zhu; Qian Feng; Rong Shen; Xing Jin
Journal:  J Thromb Thrombolysis       Date:  2020-10-09       Impact factor: 2.300

4.  Treating High-Risk TIA and Minor Stroke Patients With Dual Antiplatelet Therapy: A National Survey of Emergency Medicine Physicians.

Authors:  Ava L Liberman; Andrea R Lendaris; Natalie T Cheng; Nicole L Kaban; Sara K Rostanski; Charles Esenwa; Benjamin R Kummer; Daniel L Labovitz; Shyam Prabhakaran; Benjamin W Friedman
Journal:  Neurohospitalist       Date:  2021-06-03

5.  Rationale and Study Design for a Single-Arm Phase IIa Study Investigating Feasibility of Preventing Ischemic Cerebrovascular Events in High-Risk Patients with Acute Non-disabling Ischemic Cerebrovascular Events Using Remote Ischemic Conditioning.

Authors:  Shi-Meng Liu; Wen-Le Zhao; Hai-Qing Song; Ran Meng; Si-Jie Li; Chang-Hong Ren; Bruce Ovbiagele; Xun-Ming Ji; Wu-Wei Feng
Journal:  Chin Med J (Engl)       Date:  2018-02-05       Impact factor: 2.628

6.  Aspirin: 120 years of innovation. A report from the 2017 Scientific Conference of the International Aspirin Foundation, 14 September 2017, Charité, Berlin.

Authors:  Jaqui Walker; Pippa Hutchison; Junbo Ge; Dong Zhao; Yongjun Wang; Peter M Rothwell; J Michael Gaziano; Andrew Chan; John Burn; John Chia; Ruth Langley; Valerie O'Donnell; Bianca Rocca; Chris Hawkey
Journal:  Ecancermedicalscience       Date:  2018-02-20

7.  A prescription support-tool for chronic management of oral antithrombotic combinations in adults based on a systematic review of international guidelines.

Authors:  Lorene Zerah; René-Sosata Bun; Sylvie Guillo; Jean-Philippe Collet; Dominique Bonnet-Zamponi; Florence Tubach
Journal:  PLoS One       Date:  2019-02-14       Impact factor: 3.240

Review 8.  Chinese Stroke Center Alliance: a national effort to improve healthcare quality for acute stroke and transient ischaemic attack: rationale, design and preliminary findings.

Authors:  Yongjun Wang; Zixiao Li; Yilong Wang; Xingquan Zhao; Liping Liu; Xin Yang; Caiyun Wang; Hongqiu Gu; Fuying Zhang; Chunjuan Wang; Ying Xian; David Z Wang; Qiang Dong; Anding Xu; Jizong Zhao
Journal:  Stroke Vasc Neurol       Date:  2018-09-08

9.  HMG-CoA Reductase Inhibitors Attenuate Neuronal Damage by Suppressing Oxygen Glucose Deprivation-Induced Activated Microglial Cells.

Authors:  Dan Lu; Lingling Shen; Hongcheng Mai; Jiankun Zang; Yanfang Liu; Chi-Kwan Tsang; Keshen Li; Anding Xu
Journal:  Neural Plast       Date:  2019-02-17       Impact factor: 3.599

10.  Analytical validation of GMEX rapid point-of-care CYP2C19 genotyping system for the CHANCE-2 trial.

Authors:  Xia Meng; Anxin Wang; Guojun Zhang; Siying Niu; Wei Li; Sifei Han; Fang Fang; Xingquan Zhao; Kehui Dong; Zening Jin; Huaguang Zheng; Kelin Chen; Hao Li; Chengyuan Yang; Yongjun Wang
Journal:  Stroke Vasc Neurol       Date:  2021-05-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.